Sharps Technology Files Proxy Materials

TL;DR

Sharps Tech dropped more proxy docs, no fee. Standard shareholder stuff.

AI Summary

Sharps Technology Inc. filed a Definitive Additional Materials (DEFA14A) on September 30, 2024. This filing is related to proxy materials and does not require a fee. The company is incorporated in Nevada and its fiscal year ends on December 31st. Its principal business address is in Melville, NY.

Why It Matters

This filing indicates that Sharps Technology Inc. is providing additional materials to shareholders, likely in preparation for a shareholder meeting or vote, which is a standard corporate governance process.

Risk Assessment

Risk Level: low — This is a routine SEC filing for proxy materials and does not contain information that inherently increases risk.

Key Players & Entities

• Sharps Technology Inc. (company) — Registrant
• 0001493152-24-038697.txt (document) — Filing identifier
• 20240930 (date) — Filing date
• NV (state) — State of incorporation
• 1231 (date) — Fiscal year end
• 105 MAXESS ROAD STE. 124 MELVILLE, NY 11747 (address) — Business and mailing address

FAQ

Key Financial Figures

• $0.0001 — nge on which registered Common Stock, $0.0001 par value STSS NASDAQ Capital Marke
• $1.00 — erse stock split to achieve the minimum $1.00 NASDAQ stock price requirement. If ou

Filing Documents

• formdefa14a.htm (DEFA14A) — 62KB
• 0001493152-24-038697.txt ( ) — 63KB

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 30, 2024 SHARPS TECHNOLOGY, INC. /s/ Robert Hayes Robert Hayes Chief Executive Officer Exhibit 99.1 Sharps Technology, Inc. Reminds Shareholders to Vote Before Important Shareholder Meeting on October 7, 2024 NEW YORK, Sept. 30, 2024 (GLOBE NEWSWIRE) — Sharps Technology, Inc. (NASDAQ: STSS) (the “Company”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, is reminding shareholders to vote their proxy in favor of the Company’s proposal before the shareholder meeting scheduled to be held on October 7, 2024 at 10:00 a.m. Eastern Time. “Please take a very important step to preserve your investment and to help ensure that Sharps Technology can continue to execute its business plan,” said Robert M. Hayes, Chief Executive Officer. “We are asking you to vote today ‘FOR’ the reverse split of the Company’s common stock so that we can regain compliance with NASDAQ’s minimum bid price requirement and so that our common stock can remain listed on NASDAQ. This request is consistent with the letter that was included in the Proxy materials previously sent to investors by either email or mail.” “We acknowledge your support and approval at the July 15, 2024 special shareholder meeting for up to a 1-for-8 reverse stock split. Please note that we have not implemented the reverse stock split that was approved in July,” continued Mr. Hayes. “Based on recent communications and a hearing with NASDAQ, the Board of Directors has recommended and approved a further range for the reverse stock split of 1-for-8 up to 1-for-22 to provide the best opportunity to remain NASDAQ compliant in the long-term

View Full Filing

View this DEFA14A filing on SEC EDGAR